Publications by authors named "Zeli Yin"

Claim this Profile
I
Identification of cancer-associated fibroblasts and analysis of the association of origin with endothelial-to-mesenchymal transition in hepatocellular carcinoma.
Zeli Yin, QiuXiang Wang, Zhe Xu, Kun Guo, Liming Wang

Scand J Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis reveals the prognostic value and immunomodulatory role of CTSW in breast cancer.
Xvliang Liu, Zeli Yin, Pengju Xi, Liming Wang, Jiakai Mao

Discov Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway.
Kai Gong, Bin Xu, Lian Gong, Ming Zhong, Chun Han, Zeli Yin

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma.
Zeli Yin, Yilin Song, Liming Wang

Cancer Cell Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy.
Yilin Song, Quanlin Song, Daosheng Hu, Binwen Sun, Mingwei Gao, Zeli Yin

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy.
Zeli Yin, Liming Wang

Ann Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma.
Jin Liu, Binwen Sun, Kun Guo, Zhou Yang, Yidan Zhao, Zeli Yin

Cancer Gene Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rab27B enhances drug resistance in hepatocellular carcinoma by promoting exosome-mediated drug efflux.
Rui Li, Chengyong Dong, Keqiu Jiang, Rui Sun, Yang Zhou, Zeli Yin

Carcinogenesis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.
Keqiu Jiang, Chengyong Dong, Zeli Yin, Rui Li, Jiakai Mao

Cell Death Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Xiaobin Wang, Zeli Yin, Yanyun Zhao, Miao He, Chengyong Dong

Mol Med Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
Zeli Yin, Chengyong Dong, Keqiu Jiang, Zhe Xu, Rui Li

J Hematol Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The critical role of exosomes in tumor biology.
Keqiu Jiang, Chengyong Dong, Zeli Yin, Rui Li, Qi Wang

J Cell Biochem· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
Zeli Yin, Keqiu Jiang, Rui Li, Chengyong Dong, Liming Wang

Mol Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis